By Daniel Akselrod · Licensed Attorney · July 2026

Intake Forms for Allergy and Immunology Practices: Environmental Triggers, Reaction History, and Medication Mapping

An allergy practice sees a patient who reports seasonal congestion every spring. That sounds simple enough until you learn the congestion has been worsening each year, the patient started needing a rescue inhaler two springs ago, and their child was recently diagnosed with a peanut allergy that nobody has connected to the family history. Allergy and immunology sits at a clinical crossroads where environmental science, pharmacology, emergency medicine, and pulmonology intersect, and the intake form is the instrument that either captures those intersections or lets them slip through undocumented.

Most allergy practices inherit a general medical intake and modify it with a few allergen checkboxes. That approach misses the architecture of what an allergist actually needs before the first skin prick test. A purpose-built allergy and immunology intake form captures symptom chronology, reaction severity, environmental exposure mapping, food allergy documentation, complete medication history, and asthma comorbidity screening in a structured format that directly informs which testing panels to run and whether the patient is a candidate for immunotherapy. Every section serves a clinical decision downstream, and skipping any of them means the allergist is making those decisions with incomplete data.

Allergy symptom history: seasonal patterns, perennial burden, and severity trajectory

The most critical distinction at allergy intake is whether symptoms are seasonal, perennial, or both. A patient who sneezes from March through May is telling you something fundamentally different from a patient who sneezes year-round, and a patient whose spring symptoms have gradually expanded into fall is telling you something different still. The intake form needs to capture not just what the patient is experiencing right now but how the pattern has evolved over months and years. Seasonal allergic rhinitis that started as two weeks of sneezing in April and has expanded into four months of congestion, post-nasal drip, and sinus pressure from March through June represents a progression that changes the treatment calculus entirely.

Beyond timing, the intake must document the specific symptom profile. Nasal congestion, rhinorrhea, sneezing, post-nasal drip, itchy or watery eyes, throat clearing, ear fullness, and sinus headaches each carry diagnostic weight. A patient whose primary complaint is nasal congestion without significant sneezing or eye involvement may have non-allergic rhinitis masquerading as allergy, and the intake history is the first signal that skin testing alone may not explain the clinical picture. The form should also capture the patient's own identification of triggers, however imprecise. A patient who says they feel worse after mowing the lawn, worse around cats, or worse in damp basements is giving you a preliminary exposure map that shapes the testing panel before a single wheal is measured.

Severity progression over time deserves its own dedicated section. A patient whose allergies were manageable with over-the-counter cetirizine five years ago and now require daily nasal steroids plus antihistamines with incomplete relief is on a trajectory. That trajectory matters for treatment planning because it distinguishes the patient who needs optimized pharmacotherapy from the patient who has exhausted pharmacotherapy and should be evaluated for immunotherapy, whether subcutaneous or sublingual.

Reaction documentation: anaphylaxis history is life-or-death paperwork

No section of the allergy intake form carries higher clinical stakes than reaction documentation. A patient with a history of anaphylaxis is a patient who can die from an exposure, and the intake form is where that risk is first identified, quantified, and translated into a management plan. The form must capture every significant allergic reaction the patient has experienced, including the suspected trigger, the timeline from exposure to symptom onset, the specific symptoms that developed (hives, angioedema, throat tightness, wheezing, hypotension, loss of consciousness), what treatment was administered, and whether the patient required emergency department evaluation or hospitalization.

Epinephrine use history is particularly important. Has the patient ever used an epinephrine auto-injector, and if so, how many times? Do they currently carry one? Is it expired? Have they been trained in its use? A surprising number of patients who have been prescribed epinephrine auto-injectors do not carry them consistently, do not know how to use them correctly, or are carrying expired devices. The intake form surfaces these gaps before they become emergencies. Emergency department visits for allergic reactions also need documentation, including the date, the facility, the treatment provided, and whether the patient was admitted or observed. A patient with two prior ER visits for allergic reactions and no current epinephrine prescription has a documentation gap that the allergist needs to close at the first visit.

This section also needs to distinguish between true IgE-mediated allergic reactions and adverse reactions that patients commonly describe as allergies. A patient who reports a penicillin allergy that actually consisted of mild nausea is in a fundamentally different risk category than a patient who developed hives and throat swelling within fifteen minutes of taking amoxicillin. The intake form should capture the specific symptoms and timeline of each reported drug reaction so the allergist can assess whether formal drug allergy testing is appropriate.

Environmental assessment: the home, the workplace, and the invisible exposures

Allergy is an environmental disease, and an allergy intake that does not map the patient's environment is an intake that ignores the primary driver of symptoms. The home environment section needs to go well beyond asking whether the patient has pets. It should capture the type of flooring in the bedroom and main living areas, because wall-to-wall carpet is a dust mite reservoir that hard flooring is not. It should document the age and type of bedding, whether mattress and pillow encasements are in use, the frequency of bedding washing, and the water temperature used, because dust mite allergen survives warm-water washing and requires hot water or allergen-rated detergent to neutralize. HVAC system details matter: the type of filter in use (standard fiberglass versus HEPA-rated), how frequently it is changed, whether the home has central air or window units, and whether any rooms use evaporative cooling, which introduces moisture and mold risk.

Pet exposure documentation should specify species, whether the animal lives indoors or outdoors, whether it accesses the bedroom, and how long the patient has had the animal. A patient who has lived with a cat for eight years and developed rhinitis symptoms two years ago may have developed sensitization to an allergen they previously tolerated, which is a different clinical scenario than a patient who adopted a cat six months ago and immediately started sneezing. Mold exposure questions should cover visible mold in the home, history of water damage or flooding, basement moisture, bathroom ventilation, and any musty odors. Workplace exposures add another layer: occupational allergens (latex in healthcare workers, flour dust in bakers, wood dust in carpenters, animal dander in veterinary staff) can drive symptoms that appear unrelated to work because patients do not connect their weekday rhinitis to their occupational environment.

Food allergy documentation: confirmed versus suspected, and the testing trail

Food allergy documentation at intake requires more precision than most practices currently capture. The form needs to distinguish between confirmed food allergies (positive skin prick test or specific IgE, ideally with a consistent clinical reaction history or oral food challenge), suspected food allergies (patient-reported reactions that have not been formally tested), and food intolerances that are not immunologically mediated (lactose intolerance, caffeine sensitivity, histamine intolerance from aged foods). Conflating these categories leads to unnecessary dietary restrictions that reduce quality of life, or worse, inadequate precautions around genuinely dangerous allergens.

For each reported food allergen, the intake should capture the most recent reaction, the severity, whether the patient strictly avoids the food or tolerates it in certain forms (many egg-allergic patients tolerate baked egg, and many milk-allergic patients tolerate baked milk), and the results of any prior testing. Elimination diet history is also relevant: has the patient undertaken a structured elimination diet under medical supervision, and if so, what were the results of reintroduction? Patients who have self-directed elimination diets without medical guidance often draw incorrect conclusions about which foods are responsible for their symptoms, and documenting this history helps the allergist distinguish evidence-based avoidance from anxiety-driven restriction.

Medication history: what has been tried, what is current, and what has failed

The allergy medication history is not just a list of current prescriptions. It is a treatment timeline that tells the allergist what has already been tried, at what dose, for how long, and with what result. Oral antihistamines are the starting point for most allergy patients, and the intake should capture which ones the patient has used (cetirizine, loratadine, fexofenadine, diphenhydramine), at what dose, and whether they provided adequate relief. Many patients have tried one antihistamine, found it insufficient, and concluded that antihistamines do not work for them, when in reality they may respond to a different agent or a higher dose.

Intranasal corticosteroids (fluticasone, mometasone, budesonide) are the most effective monotherapy for allergic rhinitis, and the intake must document whether the patient has used them, for how long, and whether they used proper technique. A patient who tried fluticasone nasal spray for two weeks and stopped because it did not help may not have given the medication adequate time to reach full efficacy, which typically requires two to four weeks of consistent daily use. Prior immunotherapy history is essential: has the patient previously undergone allergy shots or sublingual immunotherapy, for which allergens, for how long, and what was the outcome? A patient who completed three years of subcutaneous immunotherapy for grass and ragweed ten years ago and is now symptomatic again presents differently than a patient who has never been offered immunotherapy. Biologic medications, particularly omalizumab for allergic asthma and chronic urticaria, should also be documented, including duration of use, response, and reason for discontinuation if applicable. The complete allergy intake form set structures this medication timeline so that nothing falls through the gap between what the patient remembers to mention and what the allergist needs to know.

Asthma comorbidity screening: the connection most intake forms miss

Allergic rhinitis and asthma are not separate diseases that happen to coexist. They are manifestations of the same atopic inflammatory process affecting different segments of the same airway, and up to forty percent of allergic rhinitis patients have concurrent asthma that may be undiagnosed or undertreated. An allergy intake form that does not screen for asthma is an intake form that will miss a comorbidity in nearly half of its patients. The screening section should capture cough frequency and triggers (exercise, cold air, laughing, nighttime), wheezing or chest tightness, shortness of breath with exertion, and nighttime awakenings due to respiratory symptoms. It should also ask whether the patient has ever been prescribed a rescue inhaler, a maintenance inhaler, or oral corticosteroids for breathing symptoms, and whether they have ever undergone spirometry or methacholine challenge testing.

This screening is not academic. A patient with uncontrolled or undiagnosed asthma who undergoes skin prick testing or begins immunotherapy without appropriate asthma management is at elevated risk for severe reactions. The intake form is where that risk is identified and addressed before testing begins. Patients who screen positive for asthma symptoms at allergy intake should have pulmonary function testing before the allergist finalizes a testing or treatment plan.

From intake to testing panel: how the form drives clinical decisions

The allergy intake form is not a bureaucratic exercise that precedes the real clinical work. It is the clinical work. Every section feeds directly into the two most consequential decisions the allergist makes at the initial visit: which allergens to test and whether the patient is a candidate for immunotherapy. A patient whose symptoms are strictly seasonal from April through June in the mid-Atlantic region needs a testing panel weighted toward tree and grass pollens. A patient with perennial symptoms, a carpeted bedroom, and no mattress encasements needs dust mite and mold panels. A patient with a cat, year-round rhinitis, and new-onset asthma symptoms needs animal dander testing with particular attention to Fel d 1 sensitization. The environmental assessment section of the intake form is, in practical terms, a testing panel selector.

Immunotherapy candidacy is equally intake-driven. The ideal immunotherapy candidate has confirmed IgE-mediated sensitivity to identifiable allergens, inadequate symptom control with pharmacotherapy, symptoms that significantly affect quality of life, and the ability to commit to a multi-year treatment protocol. Every one of those criteria is assessed through information gathered at intake: the symptom history establishes severity, the medication history establishes pharmacotherapy failure, the reaction history establishes safety parameters, and the environmental assessment establishes whether avoidance measures have been attempted and proven insufficient. An allergy intake form that captures all of this in a structured, reviewable format does not just document the patient's condition. It provides the clinical foundation for every treatment decision that follows.

Related Forms You Might Need

Allergy & immunology intake forms — $19.99 complete set

Fillable PDF intake form + client questionnaire. Symptom chronology, reaction history, environmental assessment, food allergy mapping, medication timeline, asthma screening, and immunotherapy candidacy documentation. Built for allergists and immunology practices.

View Allergy & Immunology Forms